Last update 11 Dec 2024
Interferon alfa-2b(Anhui Anke Biotechnology (Group) Co., Ltd.)
Last update 11 Dec 2024
Overview
Basic Info
Drug Type Interferons, Biosimilar |
Synonyms RHUIFNA-2B, 安达芬 |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1997), |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 26333714
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Interferon alfa-2b(Anhui Anke Biotechnology (Group) Co., Ltd.)评价人干扰素α2b 喷雾剂用于治疗儿童疱疹性咽峡炎患者的有效性和安全性的随机、双盲、安慰剂对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial to evaluate the efficacy and safety of human interferon α2b spray in the treatment of herpetic pharyngitis in children
100 Clinical Results associated with Interferon alfa-2b(Anhui Anke Biotechnology (Group) Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Interferon alfa-2b(Anhui Anke Biotechnology (Group) Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Interferon alfa-2b(Anhui Anke Biotechnology (Group) Co., Ltd.)
Login to view more data
100 Deals associated with Interferon alfa-2b(Anhui Anke Biotechnology (Group) Co., Ltd.)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Condylomata Acuminata | CN | 01 Jan 1997 | |
| Hairy Cell Leukemia | CN | 01 Jan 1997 | |
| Hepatitis B | CN | 01 Jan 1997 | |
| Hepatitis C | CN | 01 Jan 1997 | |
| Herpes Simplex | CN | 01 Jan 1997 | |
| Herpes Zoster | CN | 01 Jan 1997 | |
| Herpes Zoster Ophthalmicus | CN | 01 Jan 1997 | |
| Human Papillomavirus Infection | CN | 01 Jan 1997 | |
| Philadelphia chromosome positive chronic myelogenous leukemia | CN | 01 Jan 1997 | |
| Uterine Cervical Erosion | CN | 01 Jan 1997 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Herpangina | Phase 2 | CN | 25 May 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free